benzalkonium chloride + isopropyl myristate + liquid paraffin: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
benzalkonium chloride + isopropyl myristate + liquid paraffin: clinical details
Prescribing considerations
- Licensed as an antimicrobial bath emollient and leave-on cutaneous emulsion for dry, pruritic dermatoses.
- Counsel patients and carers about slipping, eye avoidance and the serious fire hazard from residue on fabrics.
- Consider tolerability when used as a leave-on preparation in flexures, anogenital skin or the nappy area.
Contraindications and cautions
- Hypersensitivity to benzalkonium chloride, liquid paraffin, isopropyl myristate or another formulation ingredient.
- External use only; avoid contact with the eyes.
Monitoring
- Review local irritation, itching, erythema or suspected allergic reaction.
- Reassess if the skin condition deteriorates or secondary infection is not adequately controlled.
- Check understanding of fabric fire-risk precautions.
Clinical pharmacology
The paraffin–isopropyl myristate oil phase restores surface lipids and reduces transepidermal water loss. Benzalkonium chloride is a quaternary ammonium antiseptic adsorbed onto negatively charged bacterial surfaces; systemic absorption through skin is minimal.
Formulation and product differences
- The preparation is a white cutaneous emulsion for bath-water use and direct leave-on application.
- It contains benzalkonium chloride as an antimicrobial ingredient alongside an emollient oil phase.
benzalkonium chloride + isopropyl myristate + liquid paraffin interactions
No medicinal interactions are known, but other skin treatments should be applied separately.
Topical corticosteroids and other skin treatments
Allow the first product to absorb before applying the other to avoid dilution or spreading treatment onto unaffected skin.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.